Quest Diagnostics Incorporated (DGX)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 1,102,000 | 967,000 | 1,011,000 | 1,012,000 | 1,210,000 | 1,617,000 | 1,938,000 | 2,435,000 | 2,592,000 | 2,858,000 | 2,945,000 | 2,388,000 | 1,891,000 | 1,446,000 | 978,000 | 1,016,000 | 1,105,000 | 947,000 | 931,000 | 903,000 |
| Revenue (ttm) | US$ in thousands | 9,100,000 | 9,153,000 | 9,351,000 | 9,467,000 | 9,745,000 | 10,142,000 | 10,425,000 | 10,520,000 | 10,628,000 | 10,932,000 | 10,982,000 | 10,297,000 | 9,437,000 | 8,361,000 | 7,531,000 | 7,657,000 | 7,726,000 | 7,639,000 | 7,572,000 | 7,538,000 |
| Pretax margin | 12.11% | 10.56% | 10.81% | 10.69% | 12.42% | 15.94% | 18.59% | 23.15% | 24.39% | 26.14% | 26.82% | 23.19% | 20.04% | 17.29% | 12.99% | 13.27% | 14.30% | 12.40% | 12.30% | 11.98% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $1,102,000K ÷ $9,100,000K
= 12.11%
Quest Diagnostics, Inc.'s pretax margin has shown a declining trend over the past eight quarters. In Q4 2023, the pretax margin was 12.49%, which is lower compared to the previous quarter at 11.00%. This downward trend is evident when comparing it to the same quarter in the previous year, where the pretax margin was 12.94%.
The declining pretax margin could indicate factors such as increasing expenses relative to revenue or pricing pressure in the industry, impacting profitability before taxes. It is important for Quest Diagnostics to closely monitor and manage its cost structure to improve its profitability in the future.
Peer comparison
Dec 31, 2023